The usefulness of intracellular adenosine-5'-triphosphate measurement in CD4+ cells in renal transplant
Utilidad de la medición de adenosina 5'-trifosfato intracelular en células CD4+ en trasplante renal
a Sección de Inmunología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, Spain,
b Sección de Inmunología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España,
c Servicio de Nefrología, Hospital Universitario Marqués de Valdecilla, Santander, Cantabria, España,
Leído
13232
Vecesse ha leído el artículo
3248
Total PDF
9984
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 11 | 90 | 27 | 117 |
| 2025 10 | 95 | 32 | 127 |
| 2025 9 | 99 | 38 | 137 |
| 2025 8 | 105 | 152 | 257 |
| 2025 7 | 130 | 47 | 177 |
| 2025 6 | 128 | 51 | 179 |
| 2025 5 | 142 | 38 | 180 |
| 2025 4 | 113 | 39 | 152 |
| 2025 3 | 154 | 57 | 211 |
| 2025 2 | 119 | 39 | 158 |
| 2025 1 | 95 | 31 | 126 |
| 2024 12 | 65 | 35 | 100 |
| 2024 11 | 86 | 44 | 130 |
| 2024 10 | 62 | 39 | 101 |
| 2024 9 | 78 | 35 | 113 |
| 2024 8 | 90 | 69 | 159 |
| 2024 7 | 42 | 39 | 81 |
| 2024 6 | 87 | 59 | 146 |
| 2024 5 | 76 | 40 | 116 |
| 2024 4 | 61 | 65 | 126 |
| 2024 3 | 60 | 21 | 81 |
| 2024 2 | 47 | 35 | 82 |
| 2024 1 | 43 | 23 | 66 |
| 2023 12 | 35 | 30 | 65 |
| 2023 11 | 60 | 43 | 103 |
| 2023 10 | 74 | 35 | 109 |
| 2023 9 | 66 | 35 | 101 |
| 2023 8 | 34 | 32 | 66 |
| 2023 7 | 41 | 26 | 67 |
| 2023 6 | 36 | 28 | 64 |
| 2023 5 | 53 | 32 | 85 |
| 2023 4 | 40 | 19 | 59 |
| 2023 3 | 44 | 24 | 68 |
| 2023 2 | 39 | 36 | 75 |
| 2022 1 | 49 | 18 | 67 |
| 2022 12 | 54 | 34 | 88 |
| 2022 11 | 47 | 36 | 83 |
| 2022 10 | 69 | 50 | 119 |
| 2022 9 | 47 | 27 | 74 |
| 2022 8 | 47 | 46 | 93 |
| 2022 7 | 35 | 47 | 82 |
| 2022 6 | 37 | 45 | 82 |
| 2022 5 | 28 | 35 | 63 |
| 2022 4 | 41 | 37 | 78 |
| 2022 3 | 44 | 44 | 88 |
| 2022 2 | 36 | 50 | 86 |
| 2021 1 | 34 | 66 | 100 |
| 2021 12 | 43 | 44 | 87 |
| 2021 11 | 30 | 32 | 62 |
| 2021 10 | 42 | 50 | 92 |
| 2021 9 | 37 | 51 | 88 |
| 2021 8 | 34 | 58 | 92 |
| 2021 7 | 41 | 54 | 95 |
| 2021 6 | 38 | 26 | 64 |
| 2021 5 | 46 | 31 | 77 |
| 2021 4 | 77 | 81 | 158 |
| 2021 3 | 65 | 28 | 93 |
| 2021 2 | 50 | 17 | 67 |
| 2020 1 | 34 | 24 | 58 |
| 2020 12 | 23 | 13 | 36 |
| 2020 11 | 36 | 20 | 56 |
| 2020 10 | 28 | 15 | 43 |
| 2020 9 | 26 | 12 | 38 |
| 2020 8 | 39 | 10 | 49 |
| 2020 7 | 35 | 11 | 46 |
| 2020 6 | 32 | 24 | 56 |
| 2020 5 | 32 | 11 | 43 |
| 2020 4 | 30 | 16 | 46 |
| 2020 3 | 24 | 16 | 40 |
| 2020 2 | 47 | 19 | 66 |
| 2020 1 | 38 | 19 | 57 |
| 2019 12 | 51 | 30 | 81 |
| 2019 11 | 48 | 16 | 64 |
| 2019 10 | 27 | 11 | 38 |
| 2019 9 | 36 | 19 | 55 |
| 2019 8 | 26 | 7 | 33 |
| 2019 7 | 41 | 20 | 61 |
| 2019 6 | 46 | 11 | 57 |
| 2019 5 | 48 | 6 | 54 |
| 2019 4 | 83 | 29 | 112 |
| 2019 3 | 44 | 22 | 66 |
| 2019 2 | 41 | 23 | 64 |
| 2019 1 | 57 | 22 | 79 |
| 2018 12 | 114 | 35 | 149 |
| 2018 11 | 99 | 19 | 118 |
| 2018 10 | 113 | 19 | 132 |
| 2018 9 | 101 | 8 | 109 |
| 2018 8 | 83 | 14 | 97 |
| 2018 7 | 66 | 19 | 85 |
| 2018 6 | 68 | 14 | 82 |
| 2018 5 | 68 | 13 | 81 |
| 2018 4 | 93 | 9 | 102 |
| 2018 3 | 78 | 24 | 102 |
| 2018 2 | 60 | 9 | 69 |
| 2018 1 | 72 | 6 | 78 |
| 2017 12 | 96 | 12 | 108 |
| 2017 11 | 78 | 14 | 92 |
| 2017 10 | 67 | 12 | 79 |
| 2017 9 | 70 | 11 | 81 |
| 2017 8 | 71 | 22 | 93 |
| 2017 7 | 62 | 11 | 73 |
| 2017 6 | 68 | 5 | 73 |
| 2017 5 | 102 | 12 | 114 |
| 2017 4 | 70 | 11 | 81 |
| 2017 3 | 84 | 11 | 95 |
| 2017 2 | 139 | 24 | 163 |
| 2016 1 | 44 | 19 | 63 |
| 2016 12 | 104 | 8 | 112 |
| 2016 11 | 123 | 17 | 140 |
| 2016 10 | 261 | 14 | 275 |
| 2016 9 | 441 | 6 | 447 |
| 2016 8 | 360 | 10 | 370 |
| 2016 7 | 281 | 12 | 293 |
| 2016 6 | 192 | 0 | 192 |
| 2016 5 | 158 | 0 | 158 |
| 2016 4 | 146 | 0 | 146 |
| 2016 3 | 140 | 0 | 140 |
| 2016 2 | 149 | 0 | 149 |
| 2015 1 | 140 | 0 | 140 |
| 2015 12 | 135 | 0 | 135 |
| 2015 11 | 121 | 0 | 121 |
| 2015 10 | 146 | 0 | 146 |
| 2015 9 | 111 | 0 | 111 |
| 2015 8 | 90 | 0 | 90 |
| 2015 7 | 141 | 0 | 141 |
| 2015 6 | 68 | 0 | 68 |
| 2015 5 | 73 | 0 | 73 |
| 2015 4 | 6 | 0 | 6 |
Mostrar todo
